Cellular and Molecular Life Sciences, volume 78, issue 23, pages 7777-7794
Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2
Andrei Siniavin
1, 2
,
Maria Nikiforova
2
,
Svetlana D Grinkina
2
,
В. А. Гущин
2
,
Vera A Mozhaeva
1, 4
,
Vladislav G. Starkov
1
,
Alexey V. Osipov
1
,
Sarah C.R. Lummis
5
,
V. I. Tsetlin
1
,
Publication type: Journal Article
Publication date: 2021-10-29
Journal:
Cellular and Molecular Life Sciences
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 8
ISSN: 1420682X, 14209071
PubMed ID:
34714362
Molecular Biology
Pharmacology
Cell Biology
Molecular Medicine
Cellular and Molecular Neuroscience
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 requires new treatments both to alleviate the symptoms and to prevent the spread of this disease. Previous studies demonstrated good antiviral and virucidal activity of phospholipase A2s (PLA2s) from snake venoms against viruses from different families but there was no data for coronaviruses. Here we show that PLA2s from snake venoms protect Vero E6 cells against SARS-CoV-2 cytopathic effects. PLA2s showed low cytotoxicity to Vero E6 cells with some activity at micromolar concentrations, but strong antiviral activity at nanomolar concentrations. Dimeric PLA2 from the viper Vipera nikolskii and its subunits manifested especially potent virucidal effects, which were related to their phospholipolytic activity, and inhibited cell–cell fusion mediated by the SARS-CoV-2 spike glycoprotein. Moreover, PLA2s interfered with binding both of an antibody against ACE2 and of the receptor-binding domain of the glycoprotein S to 293T/ACE2 cells. This is the first demonstration of a detrimental effect of PLA2s on β-coronaviruses. Thus, snake PLA2s are promising for the development of antiviral drugs that target the viral envelope, and could also prove to be useful tools to study the interaction of viruses with host cells. Supplementary Information The online version contains supplementary material available at 10.1007/s00018-021-03985-6.
Top-30
Journals
1
2
3
4
|
|
International Journal of Molecular Sciences
4 publications, 12.5%
|
|
Toxins
2 publications, 6.25%
|
|
International Journal of Biological Macromolecules
2 publications, 6.25%
|
|
Vaccines
2 publications, 6.25%
|
|
Frontiers in Microbiology
1 publication, 3.13%
|
|
Nature Reviews Chemistry
1 publication, 3.13%
|
|
Archives of Microbiology
1 publication, 3.13%
|
|
Trends in Endocrinology and Metabolism
1 publication, 3.13%
|
|
Toxicon: X
1 publication, 3.13%
|
|
Acta Pharmaceutica Sinica B
1 publication, 3.13%
|
|
Toxicology in Vitro
1 publication, 3.13%
|
|
Frontiers in Pharmacology
1 publication, 3.13%
|
|
Evidence-based Complementary and Alternative Medicine
1 publication, 3.13%
|
|
Bulletin of Russian State Medical University
1 publication, 3.13%
|
|
Russian Journal of Bioorganic Chemistry
1 publication, 3.13%
|
|
Biotechnology Reports
1 publication, 3.13%
|
|
Pharmaceuticals
1 publication, 3.13%
|
|
Scientific Reports
1 publication, 3.13%
|
|
Molecules
1 publication, 3.13%
|
|
Sakarya University Journal of Science
1 publication, 3.13%
|
|
Antiviral Research
1 publication, 3.13%
|
|
Heliyon
1 publication, 3.13%
|
|
Биоорганическая химия
1 publication, 3.13%
|
|
Nanoscale
1 publication, 3.13%
|
|
1
2
3
4
|
Publishers
2
4
6
8
10
12
|
|
Elsevier
11 publications, 34.38%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
10 publications, 31.25%
|
|
Springer Nature
3 publications, 9.38%
|
|
Frontiers Media S.A.
2 publications, 6.25%
|
|
Pleiades Publishing
2 publications, 6.25%
|
|
Hindawi Limited
1 publication, 3.13%
|
|
Pirogov Russian National Research Medical University
1 publication, 3.13%
|
|
Sakarya University Journal of Science
1 publication, 3.13%
|
|
Royal Society of Chemistry (RSC)
1 publication, 3.13%
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Siniavin A. et al. Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 // Cellular and Molecular Life Sciences. 2021. Vol. 78. No. 23. pp. 7777-7794.
GOST all authors (up to 50)
Copy
Siniavin A., Streltsova M. A., Nikiforova M., Kudryavtsev D. S., Grinkina S. D., Гущин В. А., Mozhaeva V. A., Starkov V. G., Osipov A. V., Lummis S. C., Tsetlin V. I., Utkin Y. N. Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 // Cellular and Molecular Life Sciences. 2021. Vol. 78. No. 23. pp. 7777-7794.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s00018-021-03985-6
UR - https://doi.org/10.1007/s00018-021-03985-6
TI - Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2
T2 - Cellular and Molecular Life Sciences
AU - Siniavin, Andrei
AU - Streltsova, Maria A
AU - Kudryavtsev, Denis S.
AU - Grinkina, Svetlana D
AU - Гущин, В. А.
AU - Mozhaeva, Vera A
AU - Starkov, Vladislav G.
AU - Lummis, Sarah C.R.
AU - Tsetlin, V. I.
AU - Utkin, Yu. N.
AU - Osipov, Alexey V.
AU - Nikiforova, Maria
PY - 2021
DA - 2021/10/29
PB - Springer Nature
SP - 7777-7794
IS - 23
VL - 78
PMID - 34714362
SN - 1420-682X
SN - 1420-9071
ER -
Cite this
BibTex
Copy
@article{2021_Siniavin,
author = {Andrei Siniavin and Maria A Streltsova and Denis S. Kudryavtsev and Svetlana D Grinkina and В. А. Гущин and Vera A Mozhaeva and Vladislav G. Starkov and Sarah C.R. Lummis and V. I. Tsetlin and Yu. N. Utkin and Alexey V. Osipov and Maria Nikiforova},
title = {Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2},
journal = {Cellular and Molecular Life Sciences},
year = {2021},
volume = {78},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1007/s00018-021-03985-6},
number = {23},
pages = {7777--7794},
doi = {10.1007/s00018-021-03985-6}
}
Cite this
MLA
Copy
Siniavin, Andrei, et al. “Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2.” Cellular and Molecular Life Sciences, vol. 78, no. 23, Oct. 2021, pp. 7777-7794. https://doi.org/10.1007/s00018-021-03985-6.